As the saying goes, a skinny camel is bigger than a horse. Moreover, Pfizer's stock price was only slightly affected, but its actual assets and liquidity were not greatly affected.

Except for the scandals that broke out during the development of certain drugs, Pfizer has not been greatly affected in other aspects.

Being able to become the number one pharmaceutical company in Sam Country, or even the number one pharmaceutical company in the world, is definitely not a simple company.

It has been able to stand in Sam Country for nearly 170 years, almost as long as Sam Country's short history. How could such a company collapse so easily?

"The lowest discount price? What price is the lowest discount price?"

Zhang Guoqing never thought that he could obtain so many drugs at cost price. Cost price was just a cover.

"Follow the lowest price offered by our company to other suppliers and then reduce it by 10%." Mark quickly gave his new quotation.

"The lowest quotation is reduced by 10%? How do I know what the lowest quotation your company gives to other suppliers? Isn't this strong enough? Otherwise, you should pay cash."

Zhang Guoqing shook his head. Quotations are too easy to falsify. If Pfizer makes a random quotation, it can be said to be the lowest quotation for the supplier. Will he accept it or not?

In fact, it can be seen that Pfizer really wants to commit fraud.

Feiyun collected relevant information from most companies last time, and the prices of various drugs given to suppliers by Pfizer were also among them.

However, Zhang Guoqing did not know about this matter, only Liu Mingyu knew about it.

Hearing that Zhang Guoqing rejected his request, Mark quickly said: "Mr. Zhang, don't worry, the price used for deduction is definitely the lowest discount on the market. If Mr. Zhang doesn't believe it, we will give you the cost price."

It’s useless because there is no standard price either.”

What Mark said was true. After thinking about it carefully, Zhang Guoqing also felt that something was wrong, and immediately responded: "Well, $400 million will be paid in cash, and the remaining $100 million will be deducted from medicines. A 10% discount in the quotation will definitely not work.

Yes, it will be reduced by 30%. If that works, I will ask my secretary to send you the name and quantity of the medicines you need later. This should be no problem, right? If there are still problems, then there is nothing I can do to help."

Mark laughed loudly and said: "Mr. Zhang, there is no problem."

Zhang Guoqing's attack was a severe one, and the lowest quotation dropped by 30%.

However, for Pfizer, a 30% decline is still profitable.

The drug cost of most drugs is not very high, mainly due to high research and development costs. Amortizing the research and development costs to each drug will naturally increase the price of the drug.

But for Pfizer, except for the newly developed drugs, the research and development costs of most drugs have already been recovered.

Therefore, even a 30% drop is not that difficult to accept for Pfizer.

Sometimes, even if they lose money, they have to win this cooperation quota, which is related to Pfizer's later development strategy.

“A pleasure to work with.”

Zhang Guoqing extended his right hand towards Mark.

“A pleasure to work with.”

Mark stood up quickly and clasped his hands tightly.

Mark was very pleased to be able to successfully complete the task this time, and his job was finally saved.

It seems that Pfizer also spent US$500 million, but unlike Ito Pharmaceutical, Ito Pharmaceutical obtained the exclusive agency rights of Neon Country, while Pfizer Pharmaceutical only obtained a published cooperation list.

As the largest country on the planet, Sam Country cannot just release the exclusive agency rights to Xingchen Pharmaceutical. It is no longer a question of how much money it will cost.

Even if the increase is increased to tens of billions of dollars, it will be useless.

It is okay to look for a large enterprise to cooperate with, and Pfizer is a good choice.

This is not exactly the reason why Pfizer spent huge sums of money to obtain a list of collaborators for clinical trials of general cancer drugs on Caucasians.

Everything needs to wait until the clinical trials are completed before we can continue to discuss it.

Mark was also very aware of this situation, so he consciously did not continue to discuss the issue of exclusive agency rights.

It's just that he didn't know that his old rival Ito Pharmaceutical had secretly obtained the exclusive agency rights for generic cancer drugs in Neon Country. If he had known, he would not have been so calm.

After talking to Mark, it was almost noon.

Zhang Guoqing directly asked representatives from other countries to gather in the large conference room No. 1 and stopped slowly negotiating with them.

Representatives sent by other companies quickly gathered in the large conference room No. 1 after receiving the notice.

A group of the top pharmaceutical companies on the planet are gathered here. It is no exaggeration to say that the products produced by these companies cover almost more than 80% of the drugs on the market.

Only Xingchen Pharmaceutical has such appeal, bringing together the world's leading pharmaceutical companies.

Although these pharmaceutical companies are not as famous as Pfizer and Ito Pharmaceuticals, they are still somewhat famous people.

After everyone received the notice, they were still a little confused. Didn't they make an appointment according to the appointment time?

Why did we suddenly have a date together?

When they saw their colleagues in the conference room, they suddenly thought of something.

Before they could ask each other about the situation, the door to the conference room opened and Zhang Guoqing walked straight to the podium.

Zhang Guoqing looked at the people in the audience and chuckled softly: "I already know your intentions. First of all, I am here to express my position on behalf of the company. Except for the agency rights of Huaxia, I can act as an agent."

It is too troublesome to negotiate with each company. It is too troublesome to bring people together and directly mention the requirements. The company that wants agency rights must follow the rules of Xingchen Pharmaceutical.

It's a seller's market now. Either accept Xingchen Pharmaceutical's conditions or leave voluntarily.

He doesn't worry that no one will buy the agency rights. If no one really buys it, it doesn't matter. At most, the company will be in trouble and just set up an international department.

As for the clinical trial issues in each country, Xingchen Pharmaceutical does not have to deal with it by itself. Those who want to win the agency will handle it all by themselves.

As soon as Zhang Guoqing finished speaking, there was a burst of heated discussion in the audience.

These companies sent people here not only hoping to get the agency rights for generic cancer drugs. Now that Xingchen Pharmaceutical has agreed to open up international agency rights, the minds of all the representatives became active for a while.

Some more conspicuous people have already reported this information back to headquarters.

Although Zhang Guoqing has not said how he obtained the agency rights for generic cancer drugs, there is no doubt that the price will be huge.
Chapter completed!